How do I find recruiting Small Cell Lung Cancer clinical trials?

Browse the actively recruiting Small Cell Lung Cancer studies listed on this page, or take an assessment to see trials you may qualify for based on your profile.

Are Small Cell Lung Cancer clinical trials free to join?

Costs, travel support, and any payment for taking part vary by study. Ask the study team what is covered before you decide to join.

Who can take part in a Small Cell Lung Cancer clinical trial?

Each study has its own eligibility criteria (for example age, disease stage, and prior treatments). This page is general information and not medical advice; discuss any specific trial with your healthcare provider to confirm whether it is appropriate for you.

Small Cell Lung Cancer Clinical Trials

Small Cell Lung Cancer clinical trials evaluate new drugs, immunotherapies, radiation approaches, and combination treatments for small Cell Lung Cancer. Corterve aggregates actively recruiting Small Cell Lung Cancer studies from the public ClinicalTrials.gov registry so you can browse them by location and eligibility. Many oncology trials enroll patients at different stages of disease, including newly diagnosed and previously treated. This is general information, not medical advice — review any study with your oncology care team before enrolling.

Browse all Small Cell Lung Cancer trials Take the assessment

Recruiting Small Cell Lung Cancer studies

Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)
NCT06095583PHASE3Shanghai Junshi Bioscience Co., Ltd.Limited-stage Small Cell Lung Cancer (LS-SCLC)Goodyear, Arizona
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
NCT07227298PHASE1, PHASE2PfizerAdvanced/Metastatic Non-Small Cell Lung CancerFayetteville, Arkansas
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
NCT06793215PHASE3Hoffmann-La RocheNon-Small Cell Lung CancerAnchorage, Alaska
Study of Izalontamab Brengitecan (BMS-986507) in Combination With Osimertinib Versus Osimertinib Monotherapy or Osimertinib in Combination With Platinum-based Chemotherapy for EGFRmt Non-small Cell Lung Cancer (IZABRIGHT-Lung02)
NCT07680790PHASE3Bristol-Myers SquibbNon-Small Cell Lung CancerBeverly Hills, California
A Study of Pembrolizumab With or Without Chemotherapy in Combination With Additional Treatments for Advanced Non-Small Cell Lung Cancer (NSCLC) (MK-3475-01G/KEYMAKER U01)
NCT06731907PHASE2Merck Sharp & Dohme LLCNon-small Cell Lung CancerLexington, Kentucky
A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)
NCT07488923PHASE1Moonlight Bio, IncSmall Cell Lung Cancer (SCLC )St Louis, Missouri
MOv19-BBz CAR T Cells in FRa+ Cancers
NCT07116057PHASE1University of PennsylvaniaMetastatic Non Small Cell Lung CancerPhiladelphia, Pennsylvania
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung Cancer
NCT07659782PHASE2Verastem, Inc.Non-Small Cell Lung CancerLos Angeles, California
A Study to Compare Setidegrasib (ASP3082) With Docetaxel, in People With Non-small Cell Lung Cancer With a KRAS G12D Mutation
NCT07566052PHASE3Astellas Pharma Global Development, Inc.Non-small Cell Lung Cancer (NSCLC)Glendale, California
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
NCT06586957PHASE1NiKang Therapeutics, Inc.Solid TumorLittle Rock, Arkansas
Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer
NCT07226999PHASE2, PHASE3PfizerSmall Cell Lung Cancer (SCLC)Fayetteville, Arkansas
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
NCT07115043PHASE1, PHASE2AstraZenecaMelanomaGrand Rapids, Michigan

See all 368 recruiting trials →

Small Cell Lung Cancer trials by state

Small Cell Lung Cancer trials by metro

Frequently asked questions

How do I find recruiting Small Cell Lung Cancer clinical trials?: Browse the actively recruiting Small Cell Lung Cancer studies listed on this page, or take an assessment to see trials you may qualify for based on your profile.
Are Small Cell Lung Cancer clinical trials free to join?: Costs, travel support, and any payment for taking part vary by study. Ask the study team what is covered before you decide to join.
Who can take part in a Small Cell Lung Cancer clinical trial?: Each study has its own eligibility criteria (for example age, disease stage, and prior treatments). This page is general information and not medical advice; discuss any specific trial with your healthcare provider to confirm whether it is appropriate for you.